Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Astria Therapeutics Q3 EPS $(0.63) Vs $(0.87) Last Year

Author: Benzinga Newsdesk | November 13, 2023 09:03am

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.63) per share. This is a 27.59 percent increase over losses of $(0.87) per share from the same period last year.

Posted In: ATXS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist